Free Trial

ZyVersa Therapeutics (ZVSA) News Today

ZyVersa Therapeutics logo
$1.91
-0.10 (-4.98%)
(As of 11/1/2024 ET)
ZyVersa Therapeutics’ Shareholder Approvals and Director Elections
ZyVersa highlights review article on inflammasome-induced inflammation
What's Going On With ZyVersa Stock?
Why Is ZyVersa Therapeutics (ZVSA) Stock Up 37% Today?
Get ZyVersa Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZVSA and its competitors with MarketBeat's FREE daily newsletter.

625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

ZVSA Media Mentions By Week

ZVSA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZVSA
News Sentiment

0.40

0.43

Average
Medical
News Sentiment

ZVSA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZVSA Articles
This Week

4

1

ZVSA Articles
Average Week

Get ZyVersa Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZVSA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ZVSA) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners